SAN DIEGO, Jan. 17, 2020 /PRNewswire/ — Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:YGYIP) for each of January, February and March 2020. The dividend will be payable on February 17, March 16 and April 15 2020 to holders of record as of January 31, February 28 and March 31 2020. The dividend will be paid in cash.
About Youngevity International, Inc.
Youngevity International, Inc. (NASDAQ: YGYI and YGYIP), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The Company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements and include statements regarding the potential transaction with Steve and Michelle Wallach, the potential of the divestiture to strengthen the opportunity for all stakeholders and focus the various divisions to thrive and better leverage their core competencies, the sales and supply agreements that will exist between the two entities, post divestiture, allowing for a seamless transition that benefits both companies, the potential transaction providing a long-term beneficial relationship between our companies and all stakeholders, the expected efficiencies from a public company expense standpoint, focusing and investing more heavily into our hemp enterprise (Khrysos Industries) and our coffee enterprise (CLR Roasters) field to finish models to maximize growth, profits, and unlock shareholder value going forward, and the expected change, if any, experienced by our distributors, our customers, and our employees. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to consummate the potential transaction with Steve and Michelle Wallach, negotiate a definitive agreement and secure all required approvals and closing conditions, including receipt of a fairness opinion and shareholder approval regarding the transaction, our ability better leverage our respective core competencies, our ability to effect a seamless transition that benefits both companies, our ability to maintain a long-term beneficial relationship between our companies and all stakeholders, our ability to implement efficiencies from a public company expense standpoint, our ability to maximize growth, profits, and unlock shareholder value going forward by focusing and investing more heavily into our hemp enterprise (Khrysos Industries) and our coffee enterprise (CLR Roasters) field to finish models, our ability to minimize the expected change experienced by our distributors, our customers, and our employees, our ability to drive revenue and further growth, our ability to return to profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), and the other factors discussed in the preliminary prospectus supplement and accompanying base prospectus and our Annual Report on Form 10-K for the year ended December 31, 2018 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Contacts
Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500
Investor Relations
YGYI Investor Relations
800.504.8650
